Intra-atrial thrombosis and homozygous factor V Leiden mutation

被引:4
|
作者
Simioni, P
Scalia, D
Tormene, D
Bongiovi, S
Sardella, C
Girolami, A
机构
[1] UNIV PADUA,SCH MED,PADUA HOSP,I-35100 PADUA,ITALY
[2] UNIV PADUA,SCH MED,INST CARDIOVASC SURG,I-35100 PADUA,ITALY
[3] PIOVE SACCO HOSP,DEPT CARDIOL,PADUA,ITALY
关键词
thrombophilia; factor V Leiden; atrial thrombosis;
D O I
10.1177/107602969700300312
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 55-year-old woman with a previous history of thrombotic manifestations developed large left atrial thrombosis. Coagulative screening demonstrated the presence of severe activated protein C resistance due to homozygous factor V Leiden mutation that could explain the thrombophilic state in this patient. No other associated coagulation defects predisposing to thrombosis were identified. At the time of diagnosis of intra-atrial thrombosis, the patient presented with a moderate mitral valve stenosis and atrial fibrillation of recent onset. Both these conditions may account for the presence of left atrial thrombosis but it is suggested that inherited thrombophilia due to homozygous factor V Leiden mutation might have represented an additional predisposing factor for the development of the thrombotic phenomenon. The role of coagulation defects predisposing to thrombosis in the pathogenesis of intracardial thrombosis in patients with or without valvular diseases is still unknown and proper studies are required.
引用
收藏
页码:215 / 217
页数:3
相关论文
共 50 条
  • [31] The common haemochromatosis mutation does not increase the risk of thrombosis in patients with factor V Leiden
    Banypersad, S
    Daly, ME
    Makris, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (03) : 842 - 843
  • [32] Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies
    Chopra, N
    Koren, S
    Greer, WL
    Fortin, PR
    Rauch, J
    Fortin, I
    Senécal, JL
    Docherty, P
    Hanly, JG
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (08) : 1683 - 1688
  • [33] Lupus anticoagulant, Factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis
    Imad Uthman
    Ismail Khalil
    Raja Sawaya
    Ali Taher
    Clinical Rheumatology, 2004, 23 : 362 - 363
  • [34] Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups
    Rios, Danyelle R. A.
    Fernandes, Ana P.
    Carvalho, Maria G.
    Figueiredo, Roberta C.
    Guimaraes, Daniela A. M.
    Reis, Daniberg R.
    Simoes e Silva, Ana C.
    Gomes, Karina B.
    Dusse, Luci M. S.
    CLINICA CHIMICA ACTA, 2011, 412 (5-6) : 425 - 429
  • [35] Lupus anticoagulant, Factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis
    Uthman, I
    Khalil, I
    Sawaya, R
    Taher, A
    CLINICAL RHEUMATOLOGY, 2004, 23 (04) : 362 - 363
  • [36] Usefulness of factor V Leiden mutation testing in clinical practice
    Blinkenberg, Ellen O.
    Kristoffersen, Ann-Helen
    Sandberg, Sverre
    Steen, Vidar M.
    Houge, Gunnar
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2010, 18 (08) : 862 - 866
  • [37] Factor V Leiden mutation and pregnancy-related complications
    Kjellberg, Ulla
    van Rooijen, Marianne
    Bremme, Katarina
    Hellgren, Margareta
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 203 (05) : 469.e1 - 469.e8
  • [38] Prenatal stroke in a neonate heterozygous for factor V Leiden mutation
    Verdu, A
    Cazorla, MR
    Moreno, JC
    Casado, LF
    BRAIN & DEVELOPMENT, 2005, 27 (06) : 451 - 454
  • [39] Usefulness of factor V Leiden mutation testing in clinical practice
    Ellen Ø Blinkenberg
    Ann-Helen Kristoffersen
    Sverre Sandberg
    Vidar M Steen
    Gunnar Houge
    European Journal of Human Genetics, 2010, 18 : 862 - 866
  • [40] Factor V Leiden mutation in Sneddon syndrome
    Besnier, R
    Francès, C
    Ankri, A
    Aiach, M
    Piette, J
    LUPUS, 2003, 12 (05) : 406 - 408